TAmiRNA is a Vienna-based Austrian start-up and specializes in the discovery and validation of microRNA biomarkers.

TAmiRNA offers a ready-to-use osteomiR™ test kit to assess fracture-risk scores in patients with osteoporosis or type-2 diabetic osteopathy.
Additionally, customized analysis service is available on request.

Key areas

  • RT-qPCR
  • microRNA
  • Precision medicine
  • Age-associated diseases
  • Osteoporosis
  • Cardiovascular diseases

Key Products

  • osteomiR test kit
  • thrombomiR test kit
  • Analytical services
  • Sample testing services
  • Biomarker development (CDx)

Link to TAmiRNA

Back to list